Chang JE, Wang T, Kim K, Folstad M, et al. Maintenance low-dose fixed duration lenalidomide and rituximab following bendamustine and rituximab induction in previously untreated chronic lymphocytic leukemia and small lymphocytic lymphoma. Leuk Lymphoma 2024 Jun 10:1-9. doi: 10.1080/10428194.2024.2360535.
PMID: 38856101